Dr. Lori Gore-Green LPM Debate
•
0 gostou•617 visualizações
This is the blog presentation of Dr. Lori Gore-Green about the potential dangers of the laparoscopic power morcellator, a gynecological tool and how physicians and regulators are treating this warning.
Recomendados
Recomendados
Mais conteúdo relacionado
Mais de Dr. Lori Gore-Green
Mais de Dr. Lori Gore-Green (20)
Último
Último (20)
Dr. Lori Gore-Green LPM Debate
- 1. Debate Over Gynecology Tool Sheds Light On Regulation By Dr. Lori Gore-Green
- 2. Doctors from all over the country are sticking by a gynecological tool even after a warning from the U.S. Food and Drug Administration about its ability to spread undetected cancer.
- 3. As reported in a recent article from the Wall Street Journal, the face off between doctors and regulators is showcasing what some might call intransigence on the part of doctors
- 4. Others might call overreach on the part of the government. What is certainly clear is that quality gynecological care lies somewhere in the middle.
- 5. The device in question is called a laparoscopic power morcellator, and it is used by its proponents to remove benign uterine growths called fibroids. The tool is normally employed during routine hysterectomies to slice and remove the fibroids through small incisions.
- 6. The issue with the morcellators is that they have the potential to leave tissue behind that can grow and then spread throughout the body, including tissue that has not been identified as malignant.
- 7. This potential threat prompted the warning from the FDA and caused many hospitals to stop using the tool, including Brigham and Women’s Hospital in Boston and Philadelphia’s Temple University Hospital.
- 8. Many insurers across the country have stopped covering procedures involving morcellators.
- 9. However, there are gynecologists who believe that reports of the threat are unwarranted and continue to use the tool routinely. Doctors like Jeffrey Thurston of Dallas say that the treatments he performs with his patients are between he and his patient, and that regulators are simply interfering.
- 10. In his practice, he has patients sign a release that states that the risk of spreading undetected sarcoma is somewhere between 1 in 300 and 1 in 1000. He also tells his patients verbally that he does not believe those numbers.
- 11. In the tug of war between the FDA and doctors, it can be difficult for patients to know whom to trust. Where one stands on the use of morcellators may have more to do with politics than any insights on patient welfare.